Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2025-08-07 00:00:00 ET · period of report 2025-07-31 · accession 0000950170-25-105258 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-07 | 2025-07-31 | SNDX | Goldan Keith A. | CFO | J - Other | $8.43 | +1,226 | 93.7K | +1% | +$10.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-31 | J | A | 1,226 | $8.43 | 93,676 | D | — | — |